Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
330.60    -3.80 (-1.14%)
Bid:
329.60
Ask:
330.80
Spread: 1.20 (0.364%)
Market Cap: £1.75b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Total Voting Rights

5 Aug 2025 08:15

RNS Number : 9188T
Hammerson PLC
05 August 2025
 

Hammerson Plc(the "Company" or "Hammerson")

Total Voting Rights and Capital

5 August 2025

The Company confirms that, following the successful non-pre-emptive placing of a total of 48,253,994 ordinary shares of 5 pence each (the "Placing Shares") in the capital of the Company as announced on 31 July 2025, a total of 32,080,390 ordinary shares (the "UK Placing Shares") were admitted to trading on the main market for listed securities of the London Stock Exchange plc and the main market for listed securities of Euronext Dublin on 5 August 2025.

As announced on 31 July 2025, subject to receipt of approval to inward list the Placing Shares from the Financial Surveillance Department of the South African Reserve Bank ("SARB Approval"), applications will be made: (i) for those 16,173,604 Placing Shares placed with placees who are South African Qualifying Investors (the "SA Placing Shares") to be admitted to (a) listing in the Equity Shares (Commercial Companies) category of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange plc; and (b) listing on the Official List of The Irish Stock Exchange plc, trading as Euronext Dublin and to trading on the main market for listed securities of Euronext Dublin; and (ii) for the Placing Shares to be admitted to listing and trading as a secondary inward listing on the Main Board of the securities exchange operated by the JSE Limited. The application for SARB Approval was submitted on 29 July 2025 and it is expected that confirmation as to whether SARB Approval has been obtained will be known no later than the end of August. Further announcements will be made by the Company at the appropriate time, as and when required.

In accordance with the requirements of the FCA's Disclosure Guidance and Transparency Rule 5.6.1A, the Company hereby notifies the market that the Company's issued share capital as of Tuesday, 5 August 2025, consists of 515,992,168 ordinary shares, of which 1,300,825 shares are held in treasury. Therefore, the total number of voting rights in the Company as of Tuesday, 5 August 2025 is 514,691,343. This figure should be used by shareholders as the denominator for calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, ordinary shares in the Company, under the Disclosure and Transparency Rules and/or the Irish Transparency (Directive 2004/109/EC) Regulations 2007, as amended.

For further information contact:

Richard Crowle

Deputy Company Secretary

+44 (0) 20 7887 1000

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRPKQBPABKDBFK
Date   Source Headline
7th May 20254:30 pmRNSTotal Voting Rights
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 202512:30 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSTransaction in Own Shares
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20252:00 pmRNSTotal Voting Rights
22nd Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20254:40 pmRNSEMTN Programme: publication of Base Prospectus
15th Apr 20253:30 pmRNSTotal Voting Rights
15th Apr 20259:30 amRNSDividend Currency Conversion Announcement
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:01 amRNSTotal Voting Rights
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20253:30 pmRNSDirector/PDMR Shareholding
8th Apr 202512:30 pmRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20253:00 pmRNSTotal Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20252:30 pmRNSTotal Voting Rights
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20251:30 pmRNSDirector Declaration
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20251:00 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20253:45 pmRNSTotal Voting Rights
25th Mar 20253:00 pmRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20253:15 pmRNSTotal Voting Rights
18th Mar 20253:00 pmRNSDirector/PDMR Shareholding
18th Mar 202511:00 amRNSAnnual Report and Notice of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.